Showing 25891 - 25900 of 27948 for "Pharmaceuticals and life sciences" with applied filters
30 March 2016 by Freddy Karyadi and Ayik Candrawulan Gunadi
Freddy Karyadi and Ayik Candrawulan Gunadi of Ali Budiardjo Nugroho Reksodiputro assess the M&A regulatory framework in Indonesia
30 March 2016 by Kazi Ershadul Alam and Imran Anwar
Kazi Ershadul Alam and Imran Anwar of Tanjib Alam assess the M&A regulatory framework in Bangladesh
30 March 2016 by Pablo A. Artagaveytia and Barbara V. Ramperti
Pablo A. Artagaveytia and Barbara V. Ramperti of Marval O'Farrell & Mairal assess the M&A regulatory framework in Argentina
30 March 2016 by Mark Anthony Fraser
Mark Anthony Fraser of Frasers Law Company assesses the M&A regulatory framework in Vietnam
30 March 2016 by Paulo Coelho da Rocha
Paulo Coelho da Rocha of Demarest Advogados assesses the M&A regulatory framework in Brazil
30 March 2016 by Cesar Arbe Saldaña
Cesar Arbe Saldaña of Arbe Abogados assesses the M&A regulatory framework in Peru
30 March 2016 by Swee Gim Cheah and Lyra Miragrace Flores
Swee Gim Cheah and Lyra Miragrace Flores of Kelvin Chia Yangon provide an update on the latest M&A trends in Myanmar
29 March 2016 by Fernando de las Cuevas and Ignacio de la Fuente
Fernando de las Cuevas and Ignacio de la Fuente of Gómez-Acebo & Pombo assess the M&A regulatory framework in Spain
29 March 2016 by Alexander Vogel, Andrea Sieber and Samuel Ljubicic
Alexander Vogel, Andrea Sieber and Samuel Ljubicic of Meyerlustenberger Lachenal assess the M&A regulatory framework in Switzerland
29 March 2016 by Lorcan Tiernan and Adrian Benson
Lorcan Tiernan and Adrian Benson of Dillon Eustace assess the M&A regulatory framework in Ireland